Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report

BMC Nephrol. 2021 Dec 29;22(1):420. doi: 10.1186/s12882-021-02643-0.

Abstract

Background: As the COVID-19 pandemic spread worldwide, case reports and small series identified its association with an increasing number of medical conditions including a propensity for thrombotic complications. And since the nephrotic syndrome is also a thrombophilic state, its co-occurrence with the SARS-CoV-2 infection is likely to be associated with an even higher risk of thrombosis, particularly in the presence of known or unknown additional risk factors. Lower extremity deep vein thrombosis (DVT) and pulmonary embolism (PE) are the most common manifestations of COVID-19-associated hypercoagulable state with other venous or arterial sites being much less frequently involved. Although splanchnic vein thrombosis (SVT) has been reported to be 25 times less common than usual site venous thromboembolism (VTE) and rarely occurs in nephrotic patients, it can have catastrophic consequences. A small number of SVT cases have been reported in COVID-19 infected patients in spite of their number exceeding 180 million worldwide.

Case presentation: An unvaccinated young adult male with steroid-dependent nephrotic syndrome (SDNS) who was in a complete nephrotic remission relapsed following contracting SARS-CoV-2 infection and developed abdominal pain and diarrhea. Abdominal US revealed portal vein thrombosis. The patient was anticoagulated, yet the SVT rapidly propagated to involve the spleno-mesenteric, intrahepatic and the right hepatic veins. In spite of mechanical thrombectomy, thrombolytics and anticoagulation, he developed mesenteric ischemia which progressed to gangrene leading to bowel resection and a complicated hospital course.

Conclusion: Our case highlights the potential for a catastrophic outcome when COVID-19 infection occurs in those with a concomitant hypercoagulable state and reminds us of the need for a careful assessment of abdominal symptoms in SARS-CoV-2 infected patients.

Keywords: Hypercoagulable state; Nephrotic syndrome; Portal vein thrombosis; SARS-CoV-2; Splanchnic vein thrombosis.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / complications*
  • Gangrene / etiology
  • Humans
  • Intestines / pathology
  • Male
  • Mesenteric Ischemia / etiology*
  • Mesenteric Ischemia / therapy
  • Nephrotic Syndrome / complications*
  • Nephrotic Syndrome / drug therapy
  • Portal System*
  • SARS-CoV-2
  • Splanchnic Circulation*
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / therapy
  • Young Adult